Directors' Dealings

RNS Number : 2575P

Immupharma PLC

23 March 2009

 



For Immediate Release

23 March 2009

ImmuPharma PLC

Directors' Dealings

Institutions increase stake

ImmuPharma PLC ('ImmuPharma' or the 'Company') (LSE:IMM) announces today that a number of existing and new blue-chip institutional investors have purchased shares from the Trusts of two of ImmuPharma's founders and Directors, Richard Warr and Dimitri Dimitriou. The Trusts each placed 2.1 million (2.7 %) ordinary shares of 10 pence each in the Company at a price of 82 pence per share to institutional investors on 19 March.

Following the disposal, the current holdings are:

Richard Warr (1)	9,778,968 ordinary shares	(12.6 %)
Dimitri Dimitriou (2)	9,778,969 ordinary shares	(12.6 %)

(1) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Warr family has a beneficial interest. 

(2) Ordinary shares of £0.10 held by Louvre Trustees Limited where the Dimitriou family has a beneficial interest. 

Richard Warr, ImmuPharma's Chairman said: 

'We are delighted with the demand from new investors, including several blue-chip funds such as Gartmore, Smith & Williamson, Aviva and Rathbones.  The allocation of these shares increases ImmuPharma's free float with the aim of improving overall liquidity.'

For further information please contact: 

ImmuPharma PLC:	[phone]
Dimitri Dimitriou, Chief Executive Officer
Richard Warr, Chairman
Panmure Gordon	[phone]
Andrew Burnett/ Rakesh Sharma (Corporate Finance)
Ashton Clanfield (Corporate Broking)
Buchanan Communications:	[phone]
Lisa Baderoon
Rebecca Skye Dietrich

More information on the company can be found at www.immupharma.com

 

END

 

 

RDSSEWFWSSUSELD